Skip to main content
SpringerLink
Log in

The monoclonal antibodies (mABs) drug market for the treatment of cancer will more than double by 2016 to $US16.7 billion,

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Decision Resources Inc.The Monoclonal Antibodies Drug Market for the Treatment of Cancer Will More Than Double to $16.7 Billion By 2016. Media Release: 10 Jun 2008. Available from: URL: http://www.decisionresources.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The monoclonal antibodies (mABs) drug market for the treatment of cancer will more than double by 2016 to $US16.7 billion,. Pharmacoecon. Outcomes News 556, 10 (2008). https://doi.org/10.2165/00151234-200805560-00031

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805560-00031

Keywords

Search

Navigation